Experimental Evidence of Persistent Androgen-Receptor-Dependency in Castration-Resistant Prostate Cancer

par Kobayashi, Takashi, Inoue, Takahiro, Kamba, Tomomi, Ogawa, Osamu
Publié 2013

Failure of Ureteric Bud Invasion : A New Model of Renal Agenesis in Mice

par Kamba, Tomomi, Higashi, Shin, Kamoto, Toshiyuki, Shisa, Hayase, Yamada, Yoshihiro, Ogawa, Osamu, Hiai, Hiroshi
Publié 2001

Outcome of different post-orchiectomy management for stage I seminoma: Japanese multi-institutional study including 425 patients

par Kamba, Tomomi, Kamoto, Toshiyuki, Okubo, Kazutoshi, Teramukai, Satoshi, Kakehi, Yoshiyuki, Matsuda, Tadashi, Ogawa, Osamu
Publié 2010

Thymic cancer mimicking a metastasis of testicular seminoma

par Fukui, Tomohiro, Terada, Naoki, Takeda, Masashi, Inoue, Takahiro, Kamba, Tomomi, Yoshimura, Koji, Chen, Fengshi, Ogawa, Osamu
Publié dans Int Cancer Conf J (2015)

CD169‐positive sinus macrophages in the lymph nodes determine bladder cancer prognosis

par Asano, Touko, Ohnishi, Koji, Shiota, Takuya, Motoshima, Takanobu, Sugiyama, Yutaka, Yatsuda, Junji, Kamba, Tomomi, Ishizaka, Kazuhiro, Komohara, Yoshihiro
Publié dans Cancer Sci (2018)

A pilot study of highly hypofractionated intensity-modulated radiation therapy over 3 weeks for localized prostate cancer

par Nakamura, Kiyonao, Ikeda, Itaru, Inokuchi, Haruo, Takayama, Kenji, Inoue, Takahiro, Kamba, Tomomi, Ogawa, Osamu, Hiraoka, Masahiro, Mizowaki, Takashi
Publié dans J Radiat Res (2018)

Manipulation of Nephron-Patterning Signals Enables Selective Induction of Podocytes from Human Pluripotent Stem Cells

par Yoshimura, Yasuhiro, Taguchi, Atsuhiro, Tanigawa, Shunsuke, Yatsuda, Junji, Kamba, Tomomi, Takahashi, Satoru, Kurihara, Hidetake, Mukoyama, Masashi, Nishinakamura, Ryuichi
Publié dans J Am Soc Nephrol (2019)

Overexpression of ETS-1 is associated with malignant biological features of prostate cancer

par Li, Bo, Shimizu, Yosuke, Kobayashi, Takashi, Terada, Naoki, Yoshimura, Koji, Kamba, Tomomi, Mikami, Yoshiki, Inoue, Takahiro, Nishiyama, Hiroyuki, Ogawa, Osamu
Publié 2012

Prognosis of Japanese patients with previously untreated metastatic renal cell carcinoma in the era of molecular-targeted therapy

par Shinohara, Nobuo, Obara, Wataru, Tatsugami, Katsunori, Naito, Sei, Kamba, Tomomi, Takahashi, Masayuki, Murai, Sachiyo, Abe, Takashige, Oba, Koji, Naito, Seiji
Publié dans Cancer Sci (2015)

Advanced prostate cancer discovered with cancerous peritonitis: Case report

par Kurahashi, Ryoma, Fukushima, Yumi, Motoshima, Takanobu, Murakami, Yoji, Yatsuda, Junji, Yamaguchi, Takahiro, Tanoue, Kenichiro, Sugiyama, Yutaka, Nishi, Kazuhiko, Kamba, Tomomi
Publié dans Urol Case Rep (2018)

Role of IL13RA2 in Sunitinib Resistance in Clear Cell Renal Cell Carcinoma

par Shibasaki, Noboru, Yamasaki, Toshinari, Kanno, Toru, Arakaki, Ryuichiro, Sakamoto, Hiromasa, Utsunomiya, Noriaki, Inoue, Takahiro, Tsuruyama, Tatsuaki, Nakamura, Eijiro, Ogawa, Osamu, Kamba, Tomomi
Publié dans PLoS One (2015)

Remarkable antitumor effect of nivolumab in a patient with metastatic renal cell carcinoma previously treated with a peptide‐based vaccine

par Kurahashi, Ryoma, Motoshima, Takanobu, Fukushima, Yumi, Murakami, Yoji, Yatsuda, Junji, Yamaguchi, Takahiro, Sugiyama, Yutaka, Fukushima, Satoshi, Komohara, Yoshihiro, Suekane, Shigetaka, Kamba, Tomomi
Publié dans IJU Case Rep (2020)

CCL2 as a potential therapeutic target for clear cell renal cell carcinoma

par Arakaki, Ryuichiro, Yamasaki, Toshinari, Kanno, Toru, Shibasaki, Noboru, Sakamoto, Hiromasa, Utsunomiya, Noriaki, Sumiyoshi, Takayuki, Shibuya, Shinsuke, Tsuruyama, Tatsuaki, Nakamura, Eijiro, Ogawa, Osamu, Kamba, Tomomi
Publié dans Cancer Med (2016)

Tumor microvasculature with endothelial fenestrations in VHL null clear cell renal cell carcinomas as a potent target of anti‐angiogenic therapy

par Yamasaki, Toshinari, Kamba, Tomomi, Kanno, Toru, Inoue, Takahiro, Shibasaki, Noboru, Arakaki, Ryuichiro, Yamada, Tomomi, Kondo, Keiichi, Kamoto, Toshiyuki, Nishiyama, Hiroyuki, Ogawa, Osamu, Nakamura, Eijiro
Publié dans Cancer Sci (2012)

Distinct Cancer-Specific Survival in Metastatic Prostate Cancer Patients Classified by a Panel of Single Nucleotide Polymorphisms of Cancer-Associated Genes

par Tsuchiya, Norihiko, Matsui, Shigeyuki, Narita, Shintaro, Kamba, Tomomi, Mitsuzuka, Koji, Hatakeyama, Shingo, Horikawa, Yohei, Inoue, Takamitsu, Saito, Seiichi, Ohyama, Chikara, Arai, Yoich, Ogawa, Osamu, Habuchi, Tomonori
Publié 2013

The Expression Profile of Phosphatidylinositol in High Spatial Resolution Imaging Mass Spectrometry as a Potential Biomarker for Prostate Cancer

par Goto, Takayuki, Terada, Naoki, Inoue, Takahiro, Nakayama, Kenji, Okada, Yoshiyuki, Yoshikawa, Takeshi, Miyazaki, Yu, Uegaki, Masayuki, Sumiyoshi, Shinji, Kobayashi, Takashi, Kamba, Tomomi, Yoshimura, Koji, Ogawa, Osamu
Publié 2014

Functional and genomic characterization of patient‐derived xenograft model to study the adaptation to mTORC1 inhibitor in clear cell renal cell carcinoma

par Sakamoto, Hiromasa, Yamasaki, Toshinari, Sumiyoshi, Takayuki, Takeda, Masashi, Shibasaki, Noboru, Utsunomiya, Noriaki, Arakaki, Ryuichiro, Akamatsu, Shusuke, Kobayashi, Takashi, Inoue, Takahiro, Kamba, Tomomi, Nakamura, Eijiro, Ogawa, Osamu
Publié dans Cancer Med (2020)

Amino‐terminal enhancer of split gene AES encodes a tumor and metastasis suppressor of prostate cancer

par Okada, Yoshiyuki, Sonoshita, Masahiro, Kakizaki, Fumihiko, Aoyama, Naoki, Itatani, Yoshiro, Uegaki, Masayuki, Sakamoto, Hiromasa, Kobayashi, Takashi, Inoue, Takahiro, Kamba, Tomomi, Suzuki, Akira, Ogawa, Osamu, Taketo, M. Mark
Publié dans Cancer Sci (2017)

Activation of Rac1 Is Closely Related to Androgen-Independent Cell Proliferation of Prostate Cancer Cells Both in Vitro and in Vivo

par Kobayashi, Takashi, Inoue, Takahiro, Shimizu, Yosuke, Terada, Naoki, Maeno, Atsushi, Kajita, Yoichiro, Yamasaki, Toshinari, Kamba, Tomomi, Toda, Yoshinobu, Mikami, Yoshiki, Yamada, Tomomi, Kamoto, Toshiyuki, Ogawa, Osamu, Nakamura, Eijiro
Publié dans Mol Endocrinol (2010)

Dual functions of angiopoietin-like protein 2 signaling in tumor progression and anti-tumor immunity

par Horiguchi, Haruki, Kadomatsu, Tsuyoshi, Kurahashi, Ryoma, Hara, Chiaki, Miyata, Keishi, Baba, Masaya, Osumi, Hironobu, Terada, Kazutoyo, Araki, Kimi, Takai, Toshiyuki, Kamba, Tomomi, Linehan, W. Marston, Moroishi, Toshiro, Oike, Yuichi
Publié dans Genes Dev (2019)